These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9665967)

  • 21. Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine.
    Vidarsson G; Sigurdardottir ST; Gudnason T; Kjartansson S; Kristinsson KG; Ingolfsdottir G; Jonsson S; Valdimarsson H; Schiffman G; Schneerson R; Jonsdottir I
    Infect Immun; 1998 Jun; 66(6):2866-70. PubMed ID: 9596761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the specificity of pneumococcal polysaccharide enzyme-linked immunosorbent assay and the effect of serum adsorption based on standard pneumococcal serogroup- or serotype-specific rabbit antisera.
    Slotved HC; Guttmann C; Pedersen CD; Jacobsen JN; Krogfelt KA
    Clin Vaccine Immunol; 2009 Sep; 16(9):1279-84. PubMed ID: 19587149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired antibody response to pneumococcal capsular polysaccharides and phosphorylcholine in adult patients with a history of bacteremic pneumococcal infection.
    Ekdahl K; Braconier JH; Svanborg C
    Clin Infect Dis; 1997 Sep; 25(3):654-60. PubMed ID: 9314455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.
    Simell B; Nurkka A; Ekström N; Givon-Lavi N; Käyhty H; Dagan R
    Clin Vaccine Immunol; 2012 Oct; 19(10):1618-23. PubMed ID: 22875604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.
    Korkeila M; Lehtonen H; Ahman H; Leroy O; Eskola J; Käyhty H
    Vaccine; 2000 Jan; 18(13):1218-26. PubMed ID: 10649623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model.
    Giebink GS; Meier JD; Quartey MK; Liebeler CL; Le CT
    J Infect Dis; 1996 Jan; 173(1):119-27. PubMed ID: 8537648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes.
    Lal G; Balmer P; Stanford E; Martin S; Warrington R; Borrow R
    J Immunol Methods; 2005 Jan; 296(1-2):135-47. PubMed ID: 15680158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides.
    Usinger WR; Lucas AH
    Infect Immun; 1999 May; 67(5):2366-70. PubMed ID: 10225896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assay.
    Marchese RD; Jain NT; Antonello J; Mallette L; Butterfield-Gerson KL; Raab J; Burke P; Schulman C; Adgate H; Sikkema DJ; Chirmule N
    Clin Vaccine Immunol; 2006 Aug; 13(8):905-12. PubMed ID: 16893991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reference ranges and cutoff levels of pneumococcal antibody global serum assays (IgG and IgG2) and specific antibodies in healthy children and adults.
    Rose MA; Buess J; Ventur Y; Zielen S; Herrmann E; Schulze J; Schubert R
    Med Microbiol Immunol; 2013 Aug; 202(4):285-94. PubMed ID: 23529214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine.
    Shahid NS; Steinhoff MC; Hoque SS; Begum T; Thompson C; Siber GR
    Lancet; 1995 Nov; 346(8985):1252-7. PubMed ID: 7475716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of IgG subclass antibodies to pneumococcal capsular polysaccharides by ELISA, using Pneumovax-specific antibodies as a reference.
    Kojima K; Ishizaka A; Oshika E; Taguchi Y; Tomizawa K; Nakanishi M; Sakiyama Y; Matsumoto S
    Tohoku J Exp Med; 1990 Jul; 161(3):209-15. PubMed ID: 2247891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
    Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
    J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a new human pneumococcal standard reference serum, 007sp.
    Goldblatt D; Plikaytis BD; Akkoyunlu M; Antonello J; Ashton L; Blake M; Burton R; Care R; Durant N; Feavers I; Fernsten P; Fievet F; Giardina P; Jansen K; Katz L; Kierstead L; Lee L; Lin J; Maisonneuve J; Nahm MH; Raab J; Romero-Steiner S; Rose C; Schmidt D; Stapleton J; Carlone GM
    Clin Vaccine Immunol; 2011 Oct; 18(10):1728-36. PubMed ID: 21852547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
    Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
    McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
    J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides.
    Pickering JW; Martins TB; Greer RW; Schroder MC; Astill ME; Litwin CM; Hildreth SW; Hill HR
    Am J Clin Pathol; 2002 Apr; 117(4):589-96. PubMed ID: 11939734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults.
    Feikin DR; Elie CM; Goetz MB; Lennox JL; Carlone GM; Romero-Steiner S; Holder PF; O'Brien WA; Whitney CG; Butler JC; Breiman RF
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):137-41. PubMed ID: 14715560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.
    Nieminen T; Käyhty H; Leroy O; Eskola J
    Pediatr Infect Dis J; 1999 Sep; 18(9):764-72. PubMed ID: 10493335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the World Health Organization Enzyme-Linked Immunosorbent Assay for the Quantitation of Immunoglobulin G Serotype-Specific Anti-Pneumococcal Antibodies in Human Serum.
    Lee H; Lim SY; Kim KH
    J Korean Med Sci; 2017 Oct; 32(10):1581-1587. PubMed ID: 28875600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.